- PhD Neuroscience, University of Georgia (2017)
- BS Animal Science, University of Georgia (2012)
In the Lab
Kinder’s research focus is in the area of regenerative bioscience with an emphasis in stem cell therapies for traumatic brain injury (TBI) and stroke. TBI and stroke are leading causes of death and disability in the United States. However, there are currently no Food and Drug Administration (FDA)-approved therapies that promote healing and restore lost function after neural injury. Neural injuries often lead to functional impairments that can significantly disrupt quality of life, therefore her research aims to understand how neural injuries may affect cognition, behavior, and motor function. In addition, she is in interested in unraveling the complex mechanisms of neural injury to identify potential treatment targets.
- Neural Regeneration Research
- Stem Cell Therapy Models
- Publications by Holly Kinder may be found at PubMed.
- For more information about courses taught by Kinder visit UGA RBIO Undergraduate program in Regenerative Bioscience.